Hip Arthritis, Hip Arthropathy, Hip Dysplasia, Hip Fractures, Hip Necrosis, Hip Osteoarthritis
Conditions
Brief summary
EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety
Detailed description
Post market observational study. This study is retropective and prospective, non comparative.
Interventions
DEVICEhip arthroplasty
Hip prosthesis surgery
Sponsors
EUROS
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patient who received EUROSCUP MOBILE. * Patient informed of its participation to the study * Patient aged between 18 and 80 years old (\<80).
Exclusion criteria
* Patient presenting a contraindication to EUROSCUP MOBILE implantation. * Patient who refused to participate to the study * Vulnerable subjects
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety of EUROSCUP MOBILE | 1 year | Collect the safety of the device trought complications occurence rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Radiological performances of EUROSCUP MOBILE | 1 year | Collect the performances of the device trought radiological evaluation |
| Clinical performances of EUROSCUP MOBILE | 1 year | Collect the performances of the device trought clinical scores |
| Survival of EUROSCUP MOBILE | 10 year | Assess the survival rate of the device |
Countries
France
Outcome results
None listed